Kris is an expert in genomic technology and systematic mapping of genetic determinants of drug resistance to pair with new therapies, and a co-inventor of Celldom technology. He is currently an Associate Professor at Duke’s Department of Pharmacology & Cancer Biology.
Sign up to view 0 direct reports
Get started